鬱血性心臟衰竭治療市場：依藥物類別、給藥途徑、通路和地區分類（2026-2034 年）

2025年，全球鬱血性心臟衰竭市場規模達104億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到256億美元，2026年至2034年的複合年成長率為10.19%。肥胖和心血管疾病盛行率的上升、人口老化以及不健康的飲食習慣是推動市場成長的主要因素。

鬱血性心臟衰竭是一種影響心肌泵血功能的疾病。其常見原因包括高血壓、冠狀動脈疾病、糖尿病、肥胖和過度飲酒。症狀包括平躺時呼吸困難、虛弱、疲勞、腹部、腿部和腳踝腫脹、夜間頻尿頻繁、噁心和注意力不集中。保持健康體重、堅持體能活動以及控制血壓和血糖值有助於預防充血性心臟衰竭。此外，還可以使用多種處方藥物進行治療，這些藥物有助於預防血栓、擴張血管、增強心肌收縮力並改善心臟功能。目前，血管張力素轉換酶抑制劑（ACEI）、配糖體、利尿劑和BETA阻斷劑是治療鬱血性心臟衰竭使用的藥物。其中，ACEI抑制血管收縮素的生成（血管張力素可收縮血管），而BETA阻斷劑則抑制某些化學物質的作用。

目前，全球老年人口的成長，尤其是易患糖尿病和慢性心血管疾病的老年人口，是推動市場成長的關鍵因素之一。此外，吸菸、飲酒和不健康的飲食習慣都會增加心臟病的風險，從而推高全球對鬱血性心臟衰竭藥物的需求。同時，肥胖和缺乏運動導致的心臟病發病率上升，也正在推動市場成長。此外，人們對早期診斷和治療心臟病益處的認知不斷提高，也為市場帶來了良好的前景。另外，對有效藥物和治療方法的需求不斷成長，以及監管機構的核准，也為主要市場參與者創造了巨大的成長機會。政府旨在改善醫療基礎設施和為患者提供最佳護理的舉措，也促進了市場成長。此外，醫院和住宅藥房的擴張，以及快速發展的電子商務行業，使得藥品更容易獲得，價格也更實惠，並提供安全的線上支付方式，預計也將推動市場成長。

目錄

第1章：序言

第2章：調查方法

• 調查目的
• 相關利益者
• 數據來源
  • 主要訊息
  • 次要訊息
• 市場估值
  • 自下而上的方法
  • 自上而下的方法
• 預測方法

第3章執行摘要

第4章：引言

第5章：全球鬱血性心臟衰竭治療市場

• 市場概覽
• 市場表現
• 新冠疫情的影響
• 市場預測

第6章 市場區隔：依藥物類別分類

• ACE抑制劑
• 血管收縮素II受體拮抗劑
• BETA阻斷劑
• 利尿劑
• 醛固酮拮抗劑
• 強心藥
• 其他

第7章 市場區隔：依給藥途徑

• 口服
• 靜脈

第8章 市場區隔：依分銷通路分類

• 醫院藥房
• 零售藥房
• 網路藥房

第9章 市場區隔：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
• 中東和非洲

第10章：促進、抑制與機遇

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

• 市場結構
• 大公司
• 主要公司簡介
  • AstraZeneca plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH（CH Boehringer Sohn Ag & Co. KG）
  • Novartis AG

The global congestive heart failure drugs market size reached USD 10.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.6 Billion by 2034, exhibiting a growth rate (CAGR) of 10.19% during 2026-2034. The rising prevalence of obesity and cardiovascular problems, increasing geriatric population and unhealthy dietary habits represent some of the key factors driving the market.

Congestive heart failure is a medical condition that affects the pumping ability of the heart muscle. It is generally caused by hypertension, coronary artery disease, diabetes, obesity, and excessive alcohol consumption. Its symptoms include shortness of breath while lying down, weakness, fatigue, swelling in the abdomen, feet, and ankles, frequent urination at night, nausea, and difficulty in concentration. It can be prevented by maintaining a healthy weight, staying physically active, and controlling blood pressure and glycemic levels. Besides this, it is controlled using various prescribed drugs that help prevent blood clots, expand blood vessels, strengthen the contractions of the heart, and improve heart functioning. At present, ACE inhibitors, vasodilators, digitalis glycosides , diuretics, and beta-blockers are some of the most prescribed congestive heart failure drugs. Amongst these, ACE inhibitors prevent the formation of angiotensin, which causes blood vessels to constrict, and beta blockers block the actions of certain chemicals.

Presently, the increasing global geriatric population, which is highly susceptible to diabetes and chronic cardiovascular diseases, represents one of the major factors positively influencing the market. In addition, excessive smoking and drinking of alcoholic beverages, coupled with unhealthy dietary habits of individuals, increases the risks of heart problems, which is catalyzing the demand for congestive heart failure drugs across the globe. This, coupled with the rising occurrence of heart problems due to obesity and lack of physical activity, is currently strengthening the growth of the market. Furthermore, the increasing awareness among individuals about the benefits of early diagnosis and treatment of heart disease is creating a positive outlook for the market. Apart from this, the escalating demand for effective drugs and treatment and their approval from authorized agencies offer lucrative growth opportunities to the leading market players. Moreover, initiatives undertaken by governments of various countries to improve healthcare infrastructure and provide optimal care to patients are contributing to the growth of the market. Additionally, the expansion of pharmacies in hospitals and residential areas and the burgeoning e-commerce industry providing easy availability of medicines at affordable rates and the facility of secured online payment methods are expected to propel the growth of the market.

KEY MARKET SEGMENTATION:

Drug Class Insights:

• ACE Inhibitors
• Angiotensin 2 Receptor Blockers
• Beta Blockers
• Diuretics
• Aldosterone Antagonists
• Inotropes
• Others

The report has also provided a detailed breakup and analysis of the congestive heart failure drugs market based on the drug class. This includes ACE inhibitors, angiotensin 2 receptor blockers, beta blockers, diuretics, aldosterone antagonists, inotropes, and others. According to the report, ACE inhibitors represented the largest segment.

Route of Administration Insights:

• Oral
• Intravenous

Distribution Channel Insights:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Regional Insights:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (The United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. According to the report, North America was the largest market for congestive heart failure drugs. Some of the factors driving the North America market included the development of healthcare infrastructure, increasing cases of heart failure and the easy availability of technologically advanced devices and innovative drugs.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global congestive heart failure drugs market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn Ag & Co. KG), Novartis AG, etc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Congestive Heart Failure Drugs Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Drug Class

• 6.1 ACE Inhibitors
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Angiotensin 2 Receptor Blockers
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Beta Blockers
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Diuretics
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Aldosterone Antagonists
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Inotropes
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Others
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast

7 Market Breakup by Route of Administration

• 7.1 Oral
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Intravenous
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

• 8.1 Hospital Pharmacies
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Retail Pharmacies
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Online Pharmacies
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

• 10.1 Overview
• 10.2 Drivers
• 10.3 Restraints
• 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 AstraZeneca plc
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Bayer AG
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn Ag & Co. KG)
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Novartis AG
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis

List of Figures

• Figure 1: Global: Congestive Heart Failure Drugs Market: Major Drivers and Challenges
• Figure 2: Global: Congestive Heart Failure Drugs Market: Sales Value (in Billion USD), 2020-2025
• Figure 3: Global: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Billion USD), 2026-2034
• Figure 4: Global: Congestive Heart Failure Drugs Market: Breakup by Drug Class (in %), 2025
• Figure 5: Global: Congestive Heart Failure Drugs Market: Breakup by Route of Administration (in %), 2025
• Figure 6: Global: Congestive Heart Failure Drugs Market: Breakup by Distribution Channel (in %), 2025
• Figure 7: Global: Congestive Heart Failure Drugs Market: Breakup by Region (in %), 2025
• Figure 8: Global: Congestive Heart Failure Drugs (ACE Inhibitors) Market: Sales Value (in Million USD), 2020 & 2025
• Figure 9: Global: Congestive Heart Failure Drugs (ACE Inhibitors) Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 10: Global: Congestive Heart Failure Drugs (Angiotensin 2 Receptor Blockers) Market: Sales Value (in Million USD), 2020 & 2025
• Figure 11: Global: Congestive Heart Failure Drugs (Angiotensin 2 Receptor Blockers) Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 12: Global: Congestive Heart Failure Drugs (Beta Blockers) Market: Sales Value (in Million USD), 2020 & 2025
• Figure 13: Global: Congestive Heart Failure Drugs (Beta Blockers) Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 14: Global: Congestive Heart Failure Drugs (Diuretics) Market: Sales Value (in Million USD), 2020 & 2025
• Figure 15: Global: Congestive Heart Failure Drugs (Diuretics) Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 16: Global: Congestive Heart Failure Drugs (Aldosterone Antagonists) Market: Sales Value (in Million USD), 2020 & 2025
• Figure 17: Global: Congestive Heart Failure Drugs (Aldosterone Antagonists) Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 18: Global: Congestive Heart Failure Drugs (Inotropes) Market: Sales Value (in Million USD), 2020 & 2025
• Figure 19: Global: Congestive Heart Failure Drugs (Inotropes) Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 20: Global: Congestive Heart Failure Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2020 & 2025
• Figure 21: Global: Congestive Heart Failure Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 22: Global: Congestive Heart Failure Drugs (Oral) Market: Sales Value (in Million USD), 2020 & 2025
• Figure 23: Global: Congestive Heart Failure Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 24: Global: Congestive Heart Failure Drugs (Intravenous) Market: Sales Value (in Million USD), 2020 & 2025
• Figure 25: Global: Congestive Heart Failure Drugs (Intravenous) Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 26: Global: Congestive Heart Failure Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
• Figure 27: Global: Congestive Heart Failure Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 28: Global: Congestive Heart Failure Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
• Figure 29: Global: Congestive Heart Failure Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 30: Global: Congestive Heart Failure Drugs (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
• Figure 31: Global: Congestive Heart Failure Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 32: North America: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 33: North America: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 34: United States: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 35: United States: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 36: Canada: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 37: Canada: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 38: Asia-Pacific: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 39: Asia-Pacific: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 40: China: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 41: China: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 42: Japan: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 43: Japan: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 44: India: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 45: India: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 46: South Korea: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 47: South Korea: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 48: Australia: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 49: Australia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 50: Indonesia: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 51: Indonesia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 52: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 53: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 54: Europe: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 55: Europe: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 56: Germany: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 57: Germany: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 58: France: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 59: France: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 60: United Kingdom: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 61: United Kingdom: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 62: Italy: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 63: Italy: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 64: Spain: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 65: Spain: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 66: Russia: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 67: Russia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 68: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 69: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 70: Latin America: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 71: Latin America: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 72: Brazil: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 73: Brazil: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 74: Mexico: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 75: Mexico: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 76: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 77: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 78: Middle East and Africa: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2020 & 2025
• Figure 79: Middle East and Africa: Congestive Heart Failure Drugs Market: Breakup by Country (in %), 2025
• Figure 80: Middle East and Africa: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2026-2034
• Figure 81: Global: Congestive Heart Failure Drugs Industry: Drivers, Restraints, and Opportunities
• Figure 82: Global: Congestive Heart Failure Drugs Industry: Value Chain Analysis
• Figure 83: Global: Congestive Heart Failure Drugs Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Congestive Heart Failure Drugs Market: Key Industry Highlights, 2025 and 2034
• Table 2: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2026-2034
• Table 3: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
• Table 4: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
• Table 5: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Region (in Million USD), 2026-2034
• Table 6: Global: Congestive Heart Failure Drugs Market: Competitive Structure
• Table 7: Global: Congestive Heart Failure Drugs Market: Key Players